InsiderSignal.AI

InsiderSignal.ai

ITGR - Integer Holdings Corp

Insider Purchase by Khales Payman (Pres, CEO)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Khales Payman, serving as Pres, CEO at Integer Holdings Corp (ITGR), purchased 3,127 shares at $64.94 per share, for a total transaction value of $203,067.00. Following this transaction, Khales Payman now holds 22,865 shares of ITGR.

This purchase represents a 16.00% increase in Khales Payman's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, October 30, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 30, 2025, meaning the disclosure happened on the same day as the trade.

Integer Holdings Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Khales Payman

Pres, CEO

Payman Khales is the President and Chief Executive Officer of Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO) serving cardiac rhythm management, neuromodulation, and cardio & vascular markets.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[3]](https://www.investing.com/news/company-news/integer-holdings-completes-leadership-transition-as-khales-becomes-ceo-93CH-4307521)[[5]](https://www.integer.net/company/our-leadership/default.aspx) He assumed this role on October 24, 2025, succeeding Joseph Dziedzic, who retired after eight years and continues as an advisor until March 31, 2026; Khales also joined the company's Board of Directors.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[2]](https://pharmasource.global/content/news/cdmo-news/integer-holdings-names-coo-payman-khales-as-next-ceo/)[[3]](https://www.investing.com/news/company-news/integer-holdings-completes-leadership-transition-as-khales-becomes-ceo-93CH-4307521) Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he implemented a market- and customer-focused strategy that doubled sales in seven years, drove above-market growth, and improved profitability and service levels.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[2]](https://pharmasource.global/content/news/cdmo-news/integer-holdings-names-coo-payman-khales-as-next-ceo/)[[5]](https://www.integer.net/company/our-leadership/default.aspx) He later served as Chief Operating Officer, overseeing both business units and global operations.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[3]](https://www.investing.com/news/company-news/integer-holdings-completes-leadership-transition-as-khales-becomes-ceo-93CH-4307521)[[5]](https://www.integer.net/company/our-leadership/default.aspx) Prior to Integer, he held senior leadership roles at CECO Environmental Corp., including President of the Environmental Technologies segment, and at Ingersoll Rand Company.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[4]](https://www.nasdaq.com/articles/integer-holdings-promotes-coo-payman-khales-succeed-joseph-dziedzic-president-and-ceo)[[5]](https://www.integer.net/company/our-leadership/default.aspx) Khales holds an Executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.[[1]](https://www.globenewswire.com/news-release/2025/10/24/3172759/0/en/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO.html)[[3]](https://www.investing.com/news/company-news/integer-holdings-completes-leadership-transition-as-khales-becomes-ceo-93CH-4307521)

View full insider profile →

Trade Price

$64.94

Quantity

3,127

Total Value

$203,067.00

Shares Owned

22,865

Trade Date

Thursday, October 30, 2025

115 days ago

SEC Filing Date

Thursday, October 30, 2025

HEALTHCAREMEDICAL DEVICES

About Integer Holdings Corp

Company Overview

No company information available
View news mentioning ITGR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/991620

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime